These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1066 related items for PubMed ID: 29578387

  • 1. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P, Bhat J, Puzyn T, Roy K.
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's disease.
    Jangid K, Devi B, Sahoo A, Kumar V, Dwivedi AR, Thareja S, Kumar R, Kumar V.
    J Biomol Struct Dyn; 2024 Mar; 42(1):509-527. PubMed ID: 37114423
    [Abstract] [Full Text] [Related]

  • 7. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
    Kumar A, Roy S, Tripathi S, Sharma A.
    J Biomol Struct Dyn; 2016 Mar; 34(2):239-49. PubMed ID: 25707809
    [Abstract] [Full Text] [Related]

  • 8. Potential Therapeutic Approaches to Alzheimer's Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools.
    Avram S, Mernea M, Limban C, Borcan F, Chifiriuc C.
    Curr Neuropharmacol; 2020 Mar; 18(8):696-719. PubMed ID: 31885353
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Determination of Potential Lead Compound from Magnolia officinalis for Alzheimer's Disease through Pharmacokinetic Prediction, Molecular Docking, Dynamic Simulation, and Experimental Validation.
    Youn K, Jun M.
    Int J Mol Sci; 2024 Sep 29; 25(19):. PubMed ID: 39408835
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phytochemicals-based β-amyloid cleaving enzyme-1 and MAO-B inhibitors for the treatment of Alzheimer's disease: molecular simulations-based predictions.
    Mahnashi MH, Ayaz M, Ghufran M, Almazni IA, Alqahtani O, Alyami BA, Alqahtani YS, Khan HA, Sadiq A, Waqas M.
    J Biomol Struct Dyn; 2024 Oct 29; 42(16):8359-8371. PubMed ID: 37815007
    [Abstract] [Full Text] [Related]

  • 14. In-silico evaluations of the isolated phytosterols from polygonum hydropiper L against BACE1 and MAO drug targets.
    Ayaz M, Wadood A, Sadiq A, Ullah F, Anichkina O, Ghufran M.
    J Biomol Struct Dyn; 2022 Oct 29; 40(20):10230-10238. PubMed ID: 34157942
    [Abstract] [Full Text] [Related]

  • 15. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
    Londhe SG, Shenoy M, Kini SG, Walhekar V, Kumar D.
    Curr Top Med Chem; 2024 Oct 29; 24(19):1738-1753. PubMed ID: 38859777
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening and in vitro biological activities study.
    Xie H, Wen H, Zhang D, Liu L, Liu B, Liu Q, Jin Q, Ke K, Hu M, Chen X.
    Oncotarget; 2017 Mar 14; 8(11):18118-18128. PubMed ID: 28179579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.